Argenx
ARGX
HK$4,628
Share price
1.47%
Change (1 day)
61.40%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
EPS for Argenx (ARGX)
EPS in 2023 (TTM): -HK$32.59
According to Argenx 's latest financial reports the company's current EPS (TTM) is -HK$32.29. In 2022 the company made an earnings per share (EPS) of -HK$101.84.
EPS history for Argenx from 2022 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -HK$32.59 | -68% |
| 2022 | -HK$101.84 |